Cerebellar liponeurocytoma

Cerebellar liponeurocytoma, also known as lipomatous medulloblastoma or lipidized medulloblastoma, is an extremely rare, low-grade (WHO grade II) brain tumor that arises in the cerebellum, the part of the brain responsible for coordination, balance, and fine motor control. This tumor is characterized by the presence of neurocytic cells with lipomatous (fat-containing) differentiation, giving it a distinctive microscopic appearance that sets it apart from other cerebellar tumors such as medulloblastoma. It predominantly affects adults, with a mean age of diagnosis typically in the fourth to sixth decades of life. Patients with cerebellar liponeurocytoma most commonly present with symptoms related to increased intracranial pressure and cerebellar dysfunction, including headaches, nausea, vomiting, gait instability (ataxia), dizziness, and impaired coordination. Because the tumor often obstructs the flow of cerebrospinal fluid, hydrocephalus (accumulation of fluid in the brain) may develop, contributing to worsening headaches and neurological deterioration. The primary treatment for cerebellar liponeurocytoma is surgical resection, with gross total removal being the goal whenever safely achievable. The prognosis is generally favorable compared to more aggressive cerebellar tumors, with many patients experiencing long-term survival. However, local recurrence has been reported in a significant proportion of cases, sometimes years or even decades after initial surgery, necessitating long-term follow-up with serial neuroimaging. The role of adjuvant radiotherapy remains debated and is typically considered in cases of subtotal resection or recurrence. Chemotherapy has not been established as a standard treatment. Fewer than 100 cases have been reported in the medical literature worldwide.

Common questions about Cerebellar liponeurocytoma